{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:16:10Z","timestamp":1790810170113,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1223,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.exphem.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T02:25:52Z","timestamp":1541471152000},"page":"10-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal"],"prefix":"10.1016","volume":"70","author":[{"given":"Jane Jialu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6027-4108","authenticated-orcid":false,"given":"Monique F.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuh Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-3168","authenticated-orcid":false,"given":"Louise E.","family":"Purton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9031","authenticated-orcid":false,"given":"Carl R.","family":"Walkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2018.11.001_bib0001","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5315\/wjh.v5.i1.1","article-title":"Insights into myelodysplastic syndromes from current preclinical models","volume":"5","author":"Tan","year":"2016","journal-title":"World J Hematol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0003","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/cncr.28641","article-title":"Underestimation of myelodysplastic syndrome incidence by cancer registries: results from a population-based data linkage study","volume":"120","author":"McQuilten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2018.11.001_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11899-015-0269-y","article-title":"Incidence and burden of the myelodysplastic syndromes","volume":"10","author":"Cogle","year":"2015","journal-title":"Curr Hematol Malig Rep."},{"key":"10.1016\/j.exphem.2018.11.001_bib0005","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","article-title":"Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registries","volume":"117","author":"Cogle","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2018.11.001_bib0007","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0008","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0009","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ajh.24253","article-title":"Myelodysplastic syndromes: contemporary review and how we treat","volume":"91","author":"Gangat","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0011","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0012","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2012-01-404863","article-title":"SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)","volume":"120","author":"Meggendorfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0013","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2012-06-440347","article-title":"Clonal architecture of chronic myelomonocytic leukemias","volume":"121","author":"Itzykson","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0014","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","article-title":"The spliceosome: design principles of a dynamic RNP machine","volume":"136","author":"Wahl","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-biochem-060614-034316","article-title":"Mechanisms and regulation of alternative pre-mRNA splicing","volume":"84","author":"Lee","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2018.11.001_bib0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.11.001_bib0018","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0019","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ccell.2015.04.007","article-title":"Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome","volume":"27","author":"Colla","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-014-0089-x","article-title":"Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk myelodysplastic syndromes with ring sideroblasts","volume":"7","author":"Visconte","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0021","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1097-2765(01)00181-2","article-title":"SC35 plays a role in T cell development and alternative splicing of CD45","volume":"7","author":"Wang","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0022","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.00202-15","article-title":"SRSF2 is essential for hematopoiesis, and its myelodysplastic syndrome-related mutations dysregulate alternative pre-mRNA splicing","volume":"35","author":"Komeno","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0023","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm.4097","article-title":"Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2018.11.001_bib0026","doi-asserted-by":"crossref","first-page":"14060","DOI":"10.1038\/ncomms14060","article-title":"Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome","volume":"8","author":"Shirai","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2018.11.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006384","article-title":"Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival","volume":"12","author":"Fei","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/j.exphem.2018.11.001_bib0028","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2016.08.006","article-title":"Physiologic expression of Sf3b1(K700E) causes impaired erythropoiesis, aberrant splicing, and sensitivity to therapeutic spliceosome modulation","volume":"30","author":"Obeng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0029","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/leu.2016.251","article-title":"Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts","volume":"31","author":"Mupo","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.11.001_bib0030","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1182\/blood-2018-04-845602","article-title":"Srsf2(P95H) initiates myeloid bias and myelodysplastic\/myeloproliferative syndrome from hemopoietic stem cells","volume":"132","author":"Smeets","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0031","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0032","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood-2017-01-762393","article-title":"Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice","volume":"131","author":"Kon","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0033","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccell.2015.04.008","article-title":"Mutant U2AF1 expression alters hematopoiesis and pre-mRNA splicing in vivo","volume":"27","author":"Shirai","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0034","doi-asserted-by":"crossref","first-page":"E10437","DOI":"10.1073\/pnas.1812669115","article-title":"Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1","volume":"115","author":"Fei","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.11.001_bib0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/45590","article-title":"Functional recognition of the 3\u2032 splice site AG by the splicing factor U2AF35","volume":"402","author":"Wu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2018.11.001_bib0038","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2005.02.018","article-title":"Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues","volume":"121","author":"Hochedlinger","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0039","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0603389103","article-title":"Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells","volume":"103","author":"Walkley","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.11.001_bib0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2007.08.016","article-title":"Limiting factors in murine hematopoietic stem cell assays","volume":"1","author":"Purton","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0041","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.stem.2013.10.010","article-title":"Deciphering hematopoietic stem cells in their niches: a critical appraisal of genetic models, lineage tracing, and imaging strategies","volume":"13","author":"Joseph","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0042","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/jbmr.2415","article-title":"Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss","volume":"30","author":"Quach","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.exphem.2018.11.001_bib0043","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature13824","article-title":"Clonal dynamics of native haematopoiesis","volume":"514","author":"Sun","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0044","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.24637","article-title":"Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Patnaik","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/leu.2015.337","article-title":"Age-related mutations and chronic myelomonocytic leukemia","volume":"30","author":"Mason","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2018.11.001_bib0046","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajh.23373","article-title":"Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance","volume":"88","author":"Patnaik","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0047","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/bjh.12756","article-title":"Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review","volume":"165","author":"Patnaik","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0048","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","article-title":"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes","volume":"119","author":"Thol","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0049","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood-2012-02-412296","article-title":"The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution","volume":"120","author":"Wu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0050","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3324\/haematol.2012.075325","article-title":"Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome","volume":"98","author":"Mian","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2018.11.001_bib0051","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.stem.2013.05.014","article-title":"SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors","volume":"13","author":"Oguro","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0052","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0053","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood-2004-08-3037","article-title":"In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis","volume":"105","author":"G\u00f6thert","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0054","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1008942828960","article-title":"Conditional gene targeting in macrophages and granulocytes using LysMcre mice","volume":"8","author":"Clausen","year":"1999","journal-title":"Transgenic Res"},{"key":"10.1016\/j.exphem.2018.11.001_bib0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.273.5272.242","article-title":"Long-term lymphohematopoietic reconstitution by a single CD34-low\/negative hematopoietic stem cell","volume":"273","author":"Osawa","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.exphem.2018.11.001_bib0056","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cell.2005.02.013","article-title":"Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment","volume":"121","author":"Adolfsson","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0057","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2004-06-2159","article-title":"Identification of Lin-Sca1+kit+CD34+Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated recipients","volume":"105","author":"Yang","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0058","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.stem.2007.07.005","article-title":"Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy","volume":"1","author":"Pronk","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0059","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progrnitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.3742","article-title":"Dynamics of clonal evolution in myelodysplastic syndromes","volume":"49","author":"Makishima","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2018.11.001_bib0061","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.exphem.2018.11.001_bib0062","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature25168","article-title":"Clonal analysis of lineage fate in native haematopoiesis","volume":"553","author":"Rodriguez-Fraticelli","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0063","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature14242","article-title":"Fundamental properties of unperturbed haematopoiesis from stem cells in vivo","volume":"518","author":"Busch","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0064","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ncb3444","article-title":"Clonal fate mapping quantifies the number of haematopoietic stem cells that arise during development","volume":"19","author":"Henninger","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2010.06.003","article-title":"Effects of the bone marrow microenvironment on hematopoietic malignancy","volume":"48","author":"Askmyr","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.exphem.2018.11.001_bib0066","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","article-title":"Chronic immune response dysregulation in MDS pathogenesis","volume":"132","author":"Barreyro","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2018.11.001_bib0067","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccr.2010.05.015","article-title":"Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells","volume":"17","author":"Mullally","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0068","doi-asserted-by":"crossref","first-page":"E3179","DOI":"10.1073\/pnas.1217812110","article-title":"Conditionals by inversion provide a universal method for the generation of conditional alleles","volume":"110","author":"Economides","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2018.11.001_bib0069","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymeth.2017.05.003","article-title":"Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines","volume":"121\u2013122","author":"Wassef","year":"2017","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2018.11.001_bib0070","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/35093537","article-title":"Conditional control of gene expression in the mouse","volume":"2","author":"Lewandoski","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.exphem.2018.11.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1002\/0471143030.cb1912s44","article-title":"Overview: generation of gene knockout mice","author":"Hall","year":"2009","journal-title":"Curr Protoc Cell Biol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0072","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-60761-974-1_12","article-title":"Generating conditional knockout mice","volume":"693","author":"Friedel","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0073","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","article-title":"Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo","volume":"25","author":"Woll","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0074","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0075","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature04980","article-title":"Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9","volume":"442","author":"Krivtsov","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0076","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"de Boer","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0077","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/gene.10161","article-title":"VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages","volume":"34","author":"Georgiades","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.exphem.2018.11.001_bib0078","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1074-7613(04)00022-6","article-title":"SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis","volume":"20","author":"Croker","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2018.11.001_bib0079","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.7660125","article-title":"Inducible gene targeting in mice","volume":"269","author":"K\u00fchn","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.exphem.2018.11.001_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stemcr.2016.06.002","article-title":"Potential pitfalls of the Mx1-Cre system: implications for experimental modeling of normal and malignant hematopoiesis","volume":"7","author":"Velasco-Hernandez","year":"2016","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.exphem.2018.11.001_bib0081","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature07815","article-title":"IFNalpha activates dormant haematopoietic stem cells in vivo","volume":"458","author":"Essers","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0082","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature09135","article-title":"Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection","volume":"465","author":"Baldridge","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2018.11.001_bib0083","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.stem.2012.02.003","article-title":"Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration","volume":"10","author":"Park","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0084","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.4049\/jimmunol.0802413","article-title":"Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2","volume":"182","author":"Higashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.stem.2014.11.002","article-title":"Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis","volume":"15","author":"S\u00e1nchez-Aguilera","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0086","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/gb-2013-14-12-r143","article-title":"The evolution, impact and properties of exonic splice enhancers","volume":"14","author":"C\u00e1ceres","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2018.11.001_bib0087","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.molcel.2006.05.008","article-title":"Comparative analysis identifies exonic splicing regulatory sequences\u2013The complex definition of enhancers and silencers","volume":"22","author":"Goren","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.exphem.2018.11.001_bib0088","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2018.11.001_bib0089","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.exphem.2018.11.001_bib0090","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00109-016-1416-1","article-title":"The role of RNA editing by ADAR1 in prevention of innate immune sensing of self-RNA","volume":"94","author":"Heraud-Farlow","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.exphem.2018.11.001_bib0091","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.2414","article-title":"Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature","volume":"44","author":"Rice","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2018.11.001_bib0092","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gr.182899.114","article-title":"Genome-wide discovery of human splicing branchpoints","volume":"25","author":"Mercer","year":"2015","journal-title":"Genome Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18308750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X18308750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:33:38Z","timestamp":1759566818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X18308750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":92,"alternative-id":["S0301472X18308750"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2018.11.001","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}